Carmen Lefaucheur

13.1k total citations · 3 hit papers
94 papers, 5.7k citations indexed

About

Carmen Lefaucheur is a scholar working on Transplantation, Surgery and Nephrology. According to data from OpenAlex, Carmen Lefaucheur has authored 94 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Transplantation, 43 papers in Surgery and 27 papers in Nephrology. Recurrent topics in Carmen Lefaucheur's work include Renal Transplantation Outcomes and Treatments (76 papers), Transplantation: Methods and Outcomes (27 papers) and Renal Diseases and Glomerulopathies (26 papers). Carmen Lefaucheur is often cited by papers focused on Renal Transplantation Outcomes and Treatments (76 papers), Transplantation: Methods and Outcomes (27 papers) and Renal Diseases and Glomerulopathies (26 papers). Carmen Lefaucheur collaborates with scholars based in France, United States and Canada. Carmen Lefaucheur's co-authors include Alexandre Loupy, Denis Glotz, Dominique Nochy, Gary S. Hill, Dominique Charron, Christophe Legendre, Caroline Suberbielle‐Boissel, Xavier Jouven, Jean–Paul Duong Van Huyen and Olivier Aubert and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Nature Communications.

In The Last Decade

Carmen Lefaucheur

90 papers receiving 5.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Complement-Binding Anti-HLA Antibodies and Kidney-Allograft Survival

2013 621 citations Alexandre Loupy, Carmen Lefaucheur et al. New England Journal of Medicine profile →
Preexisting Donor-Specific HLA Antibodies Predict Outcome in Kidney Transplantation

2010 610 citations Carmen Lefaucheur, Alexandre Loupy et al. Journal of the American Society of Nephrology profile →
Antibody-Mediated Rejection of Solid-Organ Allografts

2018 349 citations Alexandre Loupy, Carmen Lefaucheur New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Carmen Lefaucheur France	37	4.4k	2.7k	1.6k	1.5k	881	94	5.7k
Alexandre Loupy France	44	6.1k 1.4×	3.9k 1.4×	2.1k 1.3×	1.8k 1.2×	1.2k 1.4×	153	7.9k
B. Sis Canada	44	5.6k 1.3×	3.4k 1.2×	2.0k 1.3×	1.8k 1.2×	833 0.9×	97	7.3k
Magali Giral France	44	4.0k 0.9×	2.4k 0.9×	565 0.4×	1.9k 1.3×	933 1.1×	187	6.4k
Bernd Döhler Germany	37	3.4k 0.8×	2.2k 0.8×	600 0.4×	749 0.5×	886 1.0×	103	5.2k
John J. Friedewald United States	33	2.4k 0.5×	1.8k 0.6×	720 0.5×	441 0.3×	1.3k 1.5×	125	4.1k
Kathryn Tinckam Canada	34	2.3k 0.5×	1.8k 0.7×	568 0.4×	598 0.4×	609 0.7×	86	3.5k
Alan Wilkinson United States	38	2.9k 0.7×	2.5k 0.9×	494 0.3×	551 0.4×	786 0.9×	69	5.1k
J. Michael Cecka United States	42	4.7k 1.1×	3.9k 1.4×	835 0.5×	747 0.5×	2.9k 3.3×	123	7.0k
John F. Neylan United States	30	3.2k 0.7×	2.0k 0.7×	584 0.4×	467 0.3×	976 1.1×	59	5.2k
Ginny L. Bumgardner United States	32	1.9k 0.4×	1.7k 0.6×	338 0.2×	806 0.5×	679 0.8×	136	3.7k

Countries citing papers authored by Carmen Lefaucheur

Since Specialization

Citations

This map shows the geographic impact of Carmen Lefaucheur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmen Lefaucheur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmen Lefaucheur more than expected).

Fields of papers citing papers by Carmen Lefaucheur

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carmen Lefaucheur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmen Lefaucheur. The network helps show where Carmen Lefaucheur may publish in the future.

Co-authorship network of co-authors of Carmen Lefaucheur

This figure shows the co-authorship network connecting the top 25 collaborators of Carmen Lefaucheur. A scholar is included among the top collaborators of Carmen Lefaucheur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carmen Lefaucheur. Carmen Lefaucheur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Demir, Zeynep, Marc Raynaud, Gillian Divard, et al.. (2025). Impact of HLA evolutionary divergence and donor-recipient molecular mismatches on antibody-mediated rejection of kidney allografts. Nature Communications. 16(1). 5692–5692. 1 indexed citations

Xu, Qingfu, et al.. (2024). Imputing high-resolution genotypes from serological typing in a large clinical cohort. Human Immunology. 85. 110876–110876. 1 indexed citations

Divard, Gillian, et al.. (2024). BK Polyomavirus Infection in Kidney Transplantation: A Comprehensive Review of Current Challenges and Future Directions. International Journal of Molecular Sciences. 25(23). 12801–12801. 3 indexed citations

Louis, Kévin, Tracy Tabib, Camila Macedo, et al.. (2024). High-dimensional profiling of immune responses to kidney transplant reveals heterogeneous T helper 1 and B cell effectors associated with rejection. American Journal of Transplantation. 25(4). 706–719. 1 indexed citations

Bailly, É., Camila Macedo, Kévin Louis, et al.. (2023). Interleukin-21 promotes Type-1 activation and cytotoxicity of CD56dimCD16bright natural killer cells during kidney allograft antibody–mediated rejection showing a new link between adaptive and innate humoral allo-immunity. Kidney International. 104(4). 707–723. 10 indexed citations

Lefaucheur, Carmen, Kévin Louis, Anna B. Morris, et al.. (2023). Clinical recommendations for posttransplant assessment of anti–HLA (Human Leukocyte Antigen) donor-specific antibodies: A Sensitization in Transplantation: Assessment of Risk consensus document. American Journal of Transplantation. 23(1). 115–132. 38 indexed citations

Louis, Kévin, É. Bailly, Camila Macedo, et al.. (2021). T-bet+CD27+CD21– B cells poised for plasma cell differentiation during antibody-mediated rejection of kidney transplants. JCI Insight. 6(12). 24 indexed citations

Louis, Kévin, Camila Macedo, É. Bailly, et al.. (2020). Coordinated Circulating T Follicular Helper and Activated B Cell Responses Underlie the Onset of Antibody-Mediated Rejection in Kidney Transplantation. Journal of the American Society of Nephrology. 31(10). 2457–2474. 36 indexed citations

Reese, Peter P., Olivier Aubert, Maarten Naesens, et al.. (2020). Assessment of the Utility of Kidney Histology as a Basis for Discarding Organs in the United States: A Comparison of International Transplant Practices and Outcomes. Journal of the American Society of Nephrology. 32(2). 397–409. 49 indexed citations

10.

Bello, Arnaud Del, Gillian Divard, Julie Bellière, et al.. (2019). Anti‐IL‐2R blockers comparing with polyclonal antibodies: Higher risk of rejection without negative mid‐term outcomes after ABO‐incompatible kidney transplantation. Clinical Transplantation. 33(10). e13681–e13681. 5 indexed citations

11.

Bentall, Andrew, Byron H. Smith, Walter D. Park, et al.. (2019). Modeling graft loss in patients with donor-specific antibody at baseline using the Birmingham-Mayo (BirMay) predictor: Implications for clinical trials. American Journal of Transplantation. 19(8). 2274–2283. 3 indexed citations

12.

Foucher, Yohann, Florent Le Borgne, Christophe Legendre, et al.. (2018). Lack of impact of pre-emptive deceased-donor kidney transplantation on graft outcomes: a propensity score-based study. Nephrology Dialysis Transplantation. 34(5). 886–891. 7 indexed citations

13.

Viglietti, Denis, Yassine Bouatou, Olivier Aubert, et al.. (2018). Complement-binding anti-HLA antibodies are independent predictors of response to treatment in kidney recipients with antibody-mediated rejection. Kidney International. 94(4). 773–787. 39 indexed citations

14.

Loupy, Alexandre & Carmen Lefaucheur. (2018). Antibody-Mediated Rejection of Solid-Organ Allografts. New England Journal of Medicine. 379(12). 1150–1160. 349 indexed citations breakdown →

15.

Loupy, Alexandre, Olivier Aubert, Babak J. Orandi, et al.. (2017). A MULTIDIMENSIONAL PROGNOSTIC SCORE AND NOMOGRAM TO PREDICT KIDNEY TRANSPLANT SURVIVAL: THE INTEGRATIVE BOX (IBOX) SYSTEM. Transplant International. 30. 55–56. 3 indexed citations

16.

Lazareth, Hélène, Maren Burbach, Clément Gosset, et al.. (2017). Renal Arterial Mycotic Aneurysm After Kidney Transplantation. Urology. 106. e7–e8. 6 indexed citations

17.

Lefaucheur, Carmen, Denis Viglietti, Massimo Mangiola, Alexandre Loupy, & Adriana Zeevi. (2017). From Humoral Theory to Performant Risk Stratification in Kidney Transplantation. Journal of Immunology Research. 2017. 1–8. 29 indexed citations

18.

Gosset, Clément, Carmen Lefaucheur, & Denis Glotz. (2014). New insights in antibody-mediated rejection. Current Opinion in Nephrology & Hypertension. 23(6). 597–604. 40 indexed citations

19.

Lefaucheur, Carmen. (2014). Complement activation in kidney transplantation: from risk stratification to therapeutic strategies. Clinical & Experimental Immunology. 178. 57–58. 2 indexed citations

20.

Viglietti, Denis, Imad Abboud, Gary S. Hill, et al.. (2014). Kidney Allograft Fibrosis After Transplantation From Uncontrolled Circulatory Death Donors. Transplantation. 99(2). 409–415. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact